Healthcare
A number of startups are emerging to cater to the longevity hype. Nick Bell might be Australia's number one advocate — and he admits it is a tough business.
Sydney healthcare startup Eucalyptus is the latest company to chase a piece of the growing longevity market with a $995-a-month program called Compound.
With its biggest revenue driver in weight loss drugs like Ozempic facing uncertainty, Eucalyptus is expanding into men's longevity. But its offering isn’t cheap.
The pharmacy software business boasts a star studded shareholder register and exposure to one of the hottest trends in the market - miracle weight loss drug Ozempic.
Up to 30,000 disability support workers are being incorrectly paid by NDIS providers, a union says, including those employed by a prominent startup backed by ASX-listed employment giant Seek.
The ACCC has raised a number of preliminary concerns about Chemist Warehouse’s $8 billion reverse merger into Sigma Healthcare. But dealmakers involved insist they were bracing for worse.
One of Australia's most high-profile AI startups is benefiting from government initiatives in England and Hong Kong. Australia's government should follow suit.
The Australian government has banned the sale of compounded Ozempic. VC-backed Eucalyptus, which will be hit by the decision, says the government is cutting off supply to those who rely on it.
It is one of the great Aussie success stories, so why has no rival managed to disrupt Pro Medicus?
